ARCHIVES

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

Q&A: Data that Killed CYP2D6 Testing Contradict Fundamental Law of Nature

May 18, 2012

O’Shaughnessy, Burris To Present for Genentech At FDA Hearing At June 28-29

June 10, 2011

Funding opportunities: ASCO breast cancer research award; Lustgarten Foundation prostate cancer research award; NCI program announcements available.

March 5, 2004

Is a New Cancer Center Always a Good Thing? UCSD To Buy Las Vegas Center at Bankruptcy Sale

January 20, 2012

DCT Board Approves $8 Million In Contract Projects For Recompetition

October 31, 1980

In Brief: Construction Grant Applications Due Oct. 1 For Funding In FY 1982; Backlog Cleared Out

June 19, 1981